The effect of follicular fluid selenium concentration on oocyte maturation in women with polycystic ovary syndrome undergoing in vitro fertilization/Intracytoplasmic sperm injection: A cross-sectional study

被引:7
|
作者
Poormoosavi, Seyedeh Mahsa [1 ]
Behmanesh, Mohammad Amin [2 ]
Varzi, Hossein Najafzadeh [3 ]
Mansouri, Shabnam [4 ]
Janati, Sima [5 ]
机构
[1] Dezful Univ Med Sci, Sch Med, Dept Histol, Res & Clin Ctr Infertil, Dezful, Iran
[2] Dezful Univ Med Sci, Sch Med, Dept Histol, Dezful, Iran
[3] Babol Univ Med Sci, Fac Med, Dept Pharmacol, Babol, Iran
[4] Dezful Univ Med Sci, Sch Med, Dezful, Iran
[5] Dezful Univ Med Sci, Sch Med, Res & Clin Ctr Infertil, Dept Obstet & Gynecol, Dezful, Iran
关键词
Polycystic ovary syndrome; Oxidative stress; Selenium; In vitro fertilization; Oocyte quality; Follicular fluid; OXIDATIVE STRESS; TURKISH WOMEN; CUMULUS CELLS; SUPPLEMENTATION; AGE; FERTILIZATION; INFERTILITY; FERTILITY; OUTCOMES; HEALTH;
D O I
10.18502/ijrm.v19i8.9616
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: A high level of free radicals and oxidative substances in women with polycystic ovary syndrome (PCOS) can affect the ovaries through oxidative stress. Antioxidants such as selenium, a vital trace element in human health, can improve the prognosis of PCOS by reducing oxidative stress. Objective: This study was performed due to the lack of comprehensive information about selenium concentration in follicular fluid and its effect on the oocyte count and quality in infertile women with PCOS. Materials and Methods: In this cross-sectional study, 78 women with PCOS referred to Umm-al-Banin Infertility Clinic Center, Ganjavian Hospital, Dezful, Iran for in-vitro fertilization from March to November 2019 were enrolled. After ovarian stimulation with the antagonist protocol, the oocytes were retrieved under transvaginal ultrasound in in-vitro fertilization/intracytoplasmic sperm injection cycles, and selenium concentrations were measured in the follicular fluid using an atomic absorption method by spectrophotometer device. Oocyte count and morphology were evaluated using inverted optical microscopy. Results: There were no significant differences between follicular fluid selenium concentrations in terms of the total number of oocytes and immature oocytes in the metaphase I and germinal vesicle stages. However, a significantly reduced number of metaphase II oocytes was observed at selenium levels < 40 mu g/dL (p = 0.001). Conclusion: Based on our results, low levels of follicular selenium concentration in infertile women with PCOS can reduce the quality and potency of oocyte maturation.
引用
收藏
页码:689 / 698
页数:10
相关论文
共 50 条
  • [21] Evaluation of follicular fluid's Beta-Human chorionic gonadotropin in the follicles of patient undergoing Intracytoplasmic sperm injection: A cross-sectional study
    Hajshafiha, Masoumeh
    Iak, Tahere Behrouzi
    Hajiloo, Nasrin
    Deldar, Yaghoub
    Ghorbani, Mina
    Haghollahi, Fedyeh
    INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE, 2018, 16 (12) : 801 - 806
  • [22] Follicular fluid leptin content correlates with insulinemia in normalweight women with polycystic ovary syndrome undergoing in vitro fertilization/embryo transfer
    Garruti, G.
    Vacca, M.
    Rotelli, M. T.
    Panzarino, M. A.
    Nocera, S.
    Cantatore, C.
    Selvaggi, L. E.
    Giorgino, F.
    DePalo, R.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 : 53 - 53
  • [23] The effect of seasonality on reproductive outcome of patients undergoing intracytoplasmic sperm injection: A descriptive cross-sectional study
    Mehrafza, Marzieh
    Asgharnia, Maryam
    Raoufi, Azadeh
    Hosseinzadeh, Elmira
    Samadnia, Sajedeh
    Roushan, Zahra Atrkar
    INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE, 2020, 18 (11) : 989 - 994
  • [24] The influence of polycystic ovary syndrome on abortion rate after in vitro fertilization/intracytoplasmic sperm injection fresh cycle pregnancy
    Dou, Qian
    Ma, Li-ying
    Li, Peng-fen
    Xu, Xiao-ting
    Yu, Guo
    Zhang, Dan
    Xiang, Yun-gai
    Tan, Li
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [25] The influence of polycystic ovary syndrome on abortion rate after in vitro fertilization/intracytoplasmic sperm injection fresh cycle pregnancy
    Qian Dou
    Li-ying Ma
    Peng-fen Li
    Xiao-ting Xu
    Guo Yu
    Dan Zhang
    Yun-gai Xiang
    Li Tan
    Scientific Reports, 13
  • [26] Association of Polycystic Ovary Syndrome Phenotypes With Adverse Pregnancy Outcomes After In-Vitro Fertilization/Intracytoplasmic Sperm Injection
    Wang, Qiumin
    Wang, Honghong
    Li, Ping
    Li, Xiufang
    Wang, Ze
    Yan, Lei
    Shi, Yuhua
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [27] Effects of follicular fluid supplementation of in-vitro maturation medium on the fertilization and development of equine oocytes after in-vitro fertilization or intracytoplasmic sperm injection
    Dell'Aquila, ME
    Cho, YS
    Minoia, P
    Traina, V
    Lacalandra, GM
    Maritato, F
    HUMAN REPRODUCTION, 1997, 12 (12) : 2766 - 2772
  • [28] Anti-Mullerian Hormone Level Determinants among Non-Polycystic-Ovary-Syndrome Women Undergoing In Vitro Fertilization: A Retrospective Cross-Sectional Study
    Kolcsar, Melinda
    Szabo, Laszlo
    Mihaly, Renata
    Vass, Erzsebet Rozalia
    Gall, Zsolt
    MEDICINA-LITHUANIA, 2024, 60 (09):
  • [29] High anti-Müllerian hormone level as a predictor of poor pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization/intracytoplasmic sperm injection: a retrospective cohort study
    Zhao, Fei
    Wen, Duo
    Zeng, Lin
    Wang, Ruiqi
    Wang, Dingran
    Xu, Huiyu
    Li, Rong
    Chi, Hongbin
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2025, 23 (01)
  • [30] N-Acetylcysteine improves oocyte and embryo quality in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection: an alternative to metformin
    Cheraghi, Ebrahim
    Mehranjani, Malek Soleimani
    Shariatzadeh, Mohammad Ali
    Esfahani, Mohammad Hossein Nasr
    Ebrahimi, Zahra
    REPRODUCTION FERTILITY AND DEVELOPMENT, 2016, 28 (06) : 723 - 731